Proportion with improvement in pain · participants with hidradenitis suppurativa
Adalimumab every other week showed no clear difference in proportion with improvement in pain compared with placebo (moderate certainty).
1 finding from 1 review
Change in Sartorius scale score (LOCF) · participants with hidradenitis suppurativa
1 finding from 1 review
At least 50% decrease in HS Severity Index · participants with hidradenitis suppurativa
Infliximab showed no clear difference in at least 50% decrease in HS Severity Index compared with placebo (moderate certainty).
1 finding from 1 review
Physician Global Assessment (Thongprasom score) · participants with hidradenitis suppurativa
Infliximab probably leads to higher physician global assessment compared with placebo (moderate certainty).
1 finding from 1 review
Secondary outcome: Dermatology Quality of Life measure · participants with hidradenitis suppurativa
1 finding from 1 review
Adverse effects (non‐serious) · participants with hidradenitis suppurativa
Topical clindamycin showed no clear difference in adverse effects (non‐serious) compared with placebo (moderate certainty).
1 finding from 1 review
Participant global assessment VAS Visual analogue scale (VAS) (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Pain VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Nodules score Nodule count · participants with hidradenitis suppurativa
1 finding from 1 review
Abscesses score Abscess count · participants with hidradenitis suppurativa
1 finding from 1 review
Physician global assessment VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Number of participants reporting non‐serious adverse effects · participants with hidradenitis suppurativa
Ethinyloestradiol and cyproterone acetate probably leads to lower number of participants reporting non‐serious adverse effects compared with ethinyloestradiol and norgestrel (moderate certainty).
1 finding from 1 review
Participant global assessment VAS Scale from: 0 to 100 · participants with hidradenitis suppurativa
1 finding from 1 review
Adverse effects ‐ complication rate at 1 week after surgery · participants with hidradenitis suppurativa
Gentamicin sponge showed no clear difference in adverse effects ‐ complication rate at 1 week after surgery compared with primary closure alone (moderate certainty).
1 finding from 1 review
Adverse effects ‐ complication rate at 3 months after surgery · participants with hidradenitis suppurativa
Gentamicin sponge showed no clear difference in adverse effects ‐ complication rate at 3 months after surgery compared with primary closure alone (moderate certainty).
1 finding from 1 review
Recurrence after surgery · participants with hidradenitis suppurativa
Gentamicin sponge showed no clear difference in recurrence rate at 3 months after surgery compared with primary closure alone (moderate certainty).
1 finding from 1 review
Participant global assessment: satisfaction with treatment Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light may leads to higher participant global assessment: satisfaction with treatment… compared with no treatment (low certainty).
1 finding from 1 review
Frequency of serious adverse effects · participants with hidradenitis suppurativa
Adalimumab weekly showed no clear difference in frequency of serious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Participant global assessment: satisfaction with treatment ‐ axilla Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light may leads to higher participant global assessment: satisfaction with treatment ‐ axilla… compared with no treatment (low certainty).
1 finding from 1 review
Participant global assessment: satisfaction with treatment ‐ groin Questionnaire · participants with hidradenitis suppurativa
Intense pulsed light showed no clear difference in participant global assessment: satisfaction with treatment ‐ groin… compared with no treatment (low certainty).
1 finding from 1 review
RR 5 [0.31, 79.94]
1 study · 8 participants
Low